STRUCTURE-BASED DRUG DESIGN OF A NOVEL SERIES OF HUMAN CATHEPSIN D INHIBITORS.

被引：0
|
作者：
Lee, Angela Y. [1 ]
Majer, Pavel [1 ]
Gulnik, Sergei V. [1 ]
Collins, Jack [1 ]
Silva, Abelardo M. [1 ]
Bhat, Narayana T. [1 ]
Erickson, John W. [1 ]
机构：
[1] Natl Canc Inst Frederick, Struct Biochem Program, SAIC Frederick, Canc Res & Dev Ctr, Frederick, MD USA
来源：
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES | 1996年 / 52卷
关键词：
D O I：
10.1107/S0108767396091155
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
PS04.12.24
引用
收藏
页码：C205 / C205
页数：1
相关论文
共 50 条
  • [1] Combination of structure-based design and combinatorial chemistry for the development of cathepsin D inhibitors.
    Kick, EK
    Roe, DC
    Skillman, AD
    Liu, GC
    Ewing, TJA
    Sun, YX
    Kuntz, ID
    Ellman, JA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 67 - ORGN
  • [2] Structure-based design of orally bioavailable cathepsin K inhibitors.
    Thompson, SK
    Michaud, E
    Halbert, SM
    Tomaszek, TA
    Tew, DG
    Zhao, BG
    Smith, WW
    Janson, CA
    D'Alessio, KJ
    McQueney, MS
    Kurdyla, J
    Jones, CS
    Abdel-Meguid, SS
    Ijames, CF
    DesJarlais, RL
    Salyers, KL
    Smith, BR
    Levy, MA
    Veber, DF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1157 - U1157
  • [3] Structure-based drug design of novel urokinase plasminogen activator inhibitors.
    Subasinghe, N
    Hoffman, J
    Rudolph, J
    Soll, R
    Wilson, K
    Randle, T
    Green, D
    Lewandowski, F
    Zhang, M
    Bone, R
    Spurlino, J
    Deckman, I
    Manthey, C
    Zhou, Z
    Sharp, C
    Kratz, D
    Grasberger, B
    DesJarlais, R
    Molloy, CJ
    Illig, C
    CLINICAL CANCER RESEARCH, 1999, 5 : 3841S - 3841S
  • [4] Structure-based drug design of HIV protease inhibitors.
    Navia, MA
    Tung, RD
    Chaturvedi, PR
    Rao, BG
    Partaledis, JA
    Kim, EE
    FASEB JOURNAL, 1996, 10 (06): : 2436 - 2436
  • [5] STRUCTURE-BASED DESIGN OF CALCINEURIN INHIBITORS.
    Kissinger, Charles R.
    Parge, Hans
    Knighton, Daniel
    Pelletier, Laura
    Tempczyk, Anna
    Tatlock, John
    Villafranca, Ernest
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C201 - C201
  • [6] Structure-based design of ricin inhibitors.
    Kerwin, SM
    Ravikumar, KS
    Miller, D
    Robertus, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U54 - U54
  • [7] Structure-based design of novel conformationally restricted HIV protease inhibitors.
    Rao, BG
    Baker, CT
    Court, JT
    Deininger, DD
    Kim, EE
    Li, B
    Novak, PM
    Salituro, FG
    Pazhanisamy, S
    Schairer, WC
    Tung, RD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 51 - COMP
  • [8] Structure-Based Drug Design Studies on a Series of Aldolase Inhibitors
    Ferreira, Leonardo G.
    dos Santos, Ricardo N.
    Andricopulo, Adriano D.
    JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2013, 24 (02) : 201 - 211
  • [9] Nonpeptide inhibitors of cathepsin G: Optimization of a novel β-ketophosphonic acid lead by structure-based drug design
    Greco, Michael N.
    Hawkins, Michael J.
    Powell, Eugene T.
    Almond, Jr., Harold R.
    Corcoran, Thomas W.
    De, Garavilla, Lawrence
    Kauffman, Jack A.
    Recacha, Rosario
    Chattopadhyay, Debashish
    Andrade-Gordon, Patricia
    Maryanoff, Bruce E.
    Journal of the American Chemical Society, 2002, 124 (15): : 3810 - 3811
  • [10] Nonpeptide inhibitors of cathepsin G:: Optimization of a novel β-ketophosphonic acid lead by structure-based drug design
    Greco, MN
    Hawkins, MJ
    Powell, ET
    Almond, HR
    Corcoran, TW
    de Garavilla, L
    Kauffman, JA
    Recacha, R
    Chattopadhyay, D
    Andrade-Gordon, P
    Maryanoff, BE
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (15) : 3810 - 3811
12345